NVCT 8-K 2026-11-04

Nuvectis Pharma, Inc. (NVCT) 8-K dated 2026-11-04 — accession 0001104659-26-122360.

Nuvectis Pharma, Inc. (NVCT) is a biotechnology company listed on NASDAQ.

NVCT: Pharma Reports Third Quarter 2026 Financial Results and Business Highli…

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for NVCT is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The NVCT SEC hub lists recent forms. The stock page is the research view.